ARENTFOX SCHIFF LLP
Lobbying for FRAGRANCE CREATORS ASSOCIATION · Fragrance industry trade association
Implementation of Modernization of Cosmetics Regulation Act (MOCRA) regarding cosmetics ingredients and products Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Policies related to corporate taxes and tax incentives, including research and experimentation expensing Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) Fiscal Year 2025 and 2026 Department of Agriculture funding regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Implementation of P.L. 114-182 (Frank R. Lautenberg Chemical Safety for the 21st Century Act), regarding provisions related to the approval of new chemicals and risk evaluations Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.